HBW-008-A

N/A

Report date: 2024/11/21 12:00:55
NME

Base Information

Drug NameHBW-008-A
Drug Alias NameHBW-008-AHBW-008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase PAK 4 inhibitors
TargetsSerine/threonine-protein kinase PAK 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHyperway Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHyperway Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A